Details for Patent: 11,219,624
✉ Email this page to a colleague
Which drugs does patent 11,219,624 protect, and when does it expire?
Patent 11,219,624 protects OPZELURA and is included in one NDA.
Protection for OPZELURA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has sixty-nine patent family members in thirty-four countries.
Summary for Patent: 11,219,624
| Title: | Topical formulation for a JAK inhibitor |
| Abstract: | This invention relates to pharmaceutical formulations for topical skin application comprising (R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]- propanenitrile, or a pharmaceutically acceptable salt thereof, and use in the treatment of skin disorders. |
| Inventor(s): | Parikh; Bhavnish (Avondale, PA), Shah; Bhavesh (San Antonio, TX), Yeleswaram; Krishnaswamy (Landenberg, PA) |
| Assignee: | INCYTE HOLDINGS CORPORATION (Wilmington, DE) |
| Application Number: | 16/948,408 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 11,219,624
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Incyte Corp | OPZELURA | ruxolitinib phosphate | CREAM;TOPICAL | 215309-001 | Sep 21, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,219,624
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 084691 | ⤷ Try a Trial | |||
| Argentina | 124134 | ⤷ Try a Trial | |||
| Australia | 2011255443 | ⤷ Try a Trial | |||
| Australia | 2014202896 | ⤷ Try a Trial | |||
| Australia | 2016204689 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
